Angiodynamics, Inc. (($ANGO)) announced an update on their ongoing clinical study. Angiodynamics, Inc. has announced a new clinical study titled ...
TipRanks on MSN
GSK’s New Phase 3 Study on Efimosfermin Alfa: A Potential Game-Changer for Liver Disease Treatment
GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. GlaxoSmithKline (GSK) has announced a new clinical study titled ‘A ...
The Premier League has traded comfort for chaos this season, and Liverpool find themselves right in the eye of it. Margins ...
Analisa Novak is a content producer for CBS News and the Emmy Award-winning "CBS Mornings." She specializes in covering live events and exclusive interviews for the show. Analisa is a United States ...
Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could nearly double by 2050. By Nina Agrawal Liver cancer kills more than 700,000 ...
5d
This woman had to campaign to find a liver donor. Transplant docs say there should be a better way
It's pretty unusual in the medical system for a patient to be tasked with finding their own cure. But that’s what happened to ...
At least 60% of liver cancers could be preventable, according to an analysis published Monday in The Lancet. Liver cancer is the sixth most common cancer in the world, with around 870,000 cases in ...
A new study has identified TRIM56, an E3 ubiquitin ligase, as a key activator of the proto-oncogene Src in hepatocellular ...
Using two types of cardiovascular drugs together could help to treat fatty liver disease and reduce the number of severe cases. This is the finding of researchers from the University of Barcelona (UB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback